4Gross G,Schofer H,Wassilew S,et al.Herpes zoster guideline of the German Dermatology Society (DDG).J Clin Virol,2003,26(3):277-289.
5Wassilew SW,Wutzler P; Brivddin Herpes Zoster Study Group.Oral brivudin in comparison with acyclovir for herpes zoster:a survey study on postherpetic neuralgia.Antiviral Res,2003,59(1):57-60.
6Wassilew SW,Wutzler P; Brivddin Herpes Zoster Study Group.Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients:results of a randomized,double-blind,multicentered study.Antiviral Res,2003,59(1):49-56.
7Wassilew S; Collaborative Brivudin PHN Study Group.Brivudin compared with famciclovir in the treatment of herpes zoster:effects in acute disease and chronic pain in immunocompetent patients.A randomized,double-blind,multinational study.J Eur Acad Dermatol Venereol,2005,19(1):47-55.
8De Clercq E.Discovery and development of BVDU (brivudin)as a therapeutic for the treatment of herpes zoster.Biochem Pharmacol,2004,68(12):2301-2315.
